|Articles|June 3, 2020
Accelerating Biopharmaceutical Tech Transfer to Address Unmet Medical Needs
Author(s)Samsung Biologics
This application note describes key activities to accelerate biopharmaceutical tech transfer to support faster development and manufacturing programs.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
What the McKesson-Precision Medicine Deal Signals for Trial Sponsors
2
GSK's Jemperli Rectal Cancer Filing Signals Biologics Capacity Shift
3
From Detection to Prediction: Modern Analytical Approaches for Nitrosamine Risk
4
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
5